GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » EV-to-EBIT

Gaush Meditech (HKSE:02407) EV-to-EBIT : -11.24 (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gaush Meditech's Enterprise Value is HK$2,774.1 Mil. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil. Therefore, Gaush Meditech's EV-to-EBIT for today is -11.24.

The historical rank and industry rank for Gaush Meditech's EV-to-EBIT or its related term are showing as below:

HKSE:02407' s EV-to-EBIT Range Over the Past 10 Years
Min: -81.01   Med: -14.95   Max: 15.82
Current: -11.11

During the past 5 years, the highest EV-to-EBIT of Gaush Meditech was 15.82. The lowest was -81.01. And the median was -14.95.

HKSE:02407's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.815 vs HKSE:02407: -11.11

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Gaush Meditech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,426.8 Mil. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil. Gaush Meditech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.55%.


Gaush Meditech EV-to-EBIT Historical Data

The historical data trend for Gaush Meditech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech EV-to-EBIT Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -29.21 16.63

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial - - -29.21 - 16.63

Competitive Comparison of Gaush Meditech's EV-to-EBIT

For the Medical Devices subindustry, Gaush Meditech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's EV-to-EBIT falls into.



Gaush Meditech EV-to-EBIT Calculation

Gaush Meditech's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2774.062/-246.754
=-11.24

Gaush Meditech's current Enterprise Value is HK$2,774.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech  (HKSE:02407) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Gaush Meditech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-246.754/5426.836
=-4.55 %

Gaush Meditech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,426.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
N/A
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Gaush Meditech (HKSE:02407) Headlines

No Headlines